Trial Search Results

Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life

The main purpose of this study is to compare Echo-guided testing to the Hemodynamic-Echo Ramp Tests to determine which method of testing provides better information for adjusting pump speed and medical treatment for Left Ventricular Assist Device (LVAD) patients. Better adjustments may provide better quality of life, exercise tolerance and reduced unwanted cardiac events over a 6-month period.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

University of Chicago

Stanford Investigator(s):


  • Procedure: Echo Guided Testing
  • Procedure: Hemodynamic-Echo Ramp Testing -




Inclusion Criteria:

   1. Patient older than 18 years

   2. Newly implanted HVAD

   3. HVAD support anticipated for at least 6 months

   4. Patient is ambulatory and discharged from hospital without inotropes

   5. Patient is between 1 and 3 months post implant

   6. Patient has not had a right heart catheterization since discharged from HVAD
   implantation hospitalization

Exclusion Criteria:

   1. The current HVAD is a replacement device

   2. Patients currently has Right Ventricle (RV) failure requiring home inotropes

   3. Inability to preformed right heart cath

   4. Inadequate echocardiographic windows

Ages Eligible for Study

18 Years - 99 Years

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Dip Banerjee, MD